Stay updated with breaking news from Johnson Amp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biosense Webster Inc. scored approval from Japan’s Ministry of Health Labour and Welfare’s (MHLW) for its Varipulse pulsed field ablation platform to treat symptomatic drug-refractory recurrent paroxysmal atrial fibrillation on Jan. 9., making it the first PFA system approved in the country.
Johnson & Johnson (NYSE:JNJ – Free Report) – Zacks Research cut their Q4 2024 EPS estimates for Johnson & Johnson in a research note issued to investors on Wednesday, January 10th. Zacks Research analyst K. Shah now expects that the company will post earnings of $2.66 per share for the quarter, down from their previous […]
Investing in companies that have raised their payouts annually for six decades or more has paid off over the long haul.
The zeal for antibody-drug conjugates (ADCs), a prominent focus for dealmaking in 2023, shows no signs of waning, as Johnson & Johnson greeted attendees of the J.P. Morgan Healthcare Conference (JPM) with news of its $2 billion buyout of Ambrx Biopharma Inc., picking up rights to an ADC platform along with a promising candidate targeting advanced prostate cancer. Under the terms, J&J agreed to acquire all outstanding shares of San Diego-based Ambrx for $28 apiece, marketing a 105% premium to the firm’s Jan. 5 closing price. Unsurprisingly, Ambrx’s stock (NASDAQ:AMAM) gained 101.5% ...
United, Alaska Air find loose bolts on Boeing MAX 9 Jets, pharma companies ignite biotech acquisition mini-spree, and other news to start your day.